A new expert discussion is changing how we think about prediabetes. Instead of viewing it as a separate condition, many clinicians now see it as an early stage of type 2 diabetes risk. Learn why early testing, wellness planning, and weight loss management can make a meaningful difference for long-term health.

A patient-friendly guide to why weight loss is not just about willpower, how the body fights change, and how primary care can support lasting results.

We want to share an important 2026 update regarding GLP-1 medications (Ozempic®, Wegovy®, Mounjaro®, and Zepbound®). Insurance carriers are requiring significantly more prior authorizations (PA)—and we are seeing more denials than in prior years.

If you’ve been told you have a “fatty liver” or the newer term MASH (metabolic dysfunction–associated steatohepatitis), you’re not alone—and you’re not stuck. MASH is rising fast alongside weight gain, insulin resistance, and type 2 diabetes. For years, everyday advice—lose weight, move more, watch carbs—was the only path forward. Important, yes, but often not enough. Now, there’s a game-changer: semaglutide (Wegovy) has received FDA approval to treat MASH with liver fibrosis, giving primary care teams and patients a powerful new option alongside nutrition, movement, and metabolic care.

Did you know that 1 in 3 adults in the U.S. has metabolic syndrome, yet most don’t even know it? This cluster of risk factors silently increases your chances of developing heart disease, diabetes, and stroke. But here’s the good news: with the right strategies, you can reverse the course and reclaim control of your health.

Navigating the world of online prescriptions can be daunting. Especially when it comes to medications like Mounjaro, used for treating type 2 diabetes. You may be wondering, "Can I get the right Mounjaro prescription online?" The answer is yes, but it's not as simple as clicking a button.